Tuberculosis - Drug resistance in Canada 2009

[Next]

Table of Contents

• Introduction
• Methods
• Results
• Discussion
• Limitations
• Conclusions
• References

Figures

• Figure 1. Reported TB drug resistance in Canada by province/territory – 2009
• Figure 2. Reported Mycobacterium tuberculosis isolates in Canada by province/territory – 2009
• Figure 3. Overall pattern of reported TB drug resistance in Canada – 2009
• Figure 4. Reported TB drug resistance in Canada by type of drug – 2009
• Figure 5. Any resistance by type of drug as a percentage of isolates tested: 1999-2009
• Figure 6. Overall pattern of reported TB drug resistance as a percentage of isolates tested: 1999-2009

Tables

• Table 1. Reported Mycobacterium tuberculosis isolates by “reporting” and “originating” province/territory, Canada – 2009
• Table 2. Overall pattern of reported TB drug resistance in Canada – 1999-2009
• Table 3. Reported MDR-TB isolates by province/territory, Canada – 2009
• Table 4. Reported TB drug resistance by sex and age group, Canada – 2009
• Table 5. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Alberta – 1999-2009
• Table 6. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, British Columbia – 1999-2009
• Table 7. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Manitoba – 1999-2009
• Table 8. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, New Brunswick – 1999-2009
• Table 9. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Newfoundland and Labrador – 1999-2009
• Table 10. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Northwest Territories – 1999-2009
• Table 11. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Nova Scotia – 1999-2009
• Table 12. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Nunavut – 1999-2009
• Table 13. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Ontario – 1999-2009
• Table 14. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Prince Edward Island – 1999-2009
• Table 15. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Quebec – 1999-2009
• Table 16. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Saskatchewan – 1999-2009
• Table 17. Reported results for routine drug susceptibility testing of MTB isolates to anti-tuberculosis drugs, Yukon – 1999-2009

APPENDICES

• Appendix 1 – Participating laboratories of the Canadian Tuberculosis Laboratory Surveillance System
• Appendix 2 – M. tuberculosis Complex Antimicrobial Susceptibility Reporting Form

[Next]